Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TACE”

589 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 589 results

Not applicableStudy completedNCT03317483
What this trial is testing

DEB-TACE Treatment in 367 Liver Cancer Patients

Who this might be right for
Liver Cancer
Zhejiang Cancer Hospital 367
Large-scale testing (Phase 3)Study completedNCT01229839
What this trial is testing

Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 668
Not applicableLooking for participantsNCT06898398
What this trial is testing

TACE Combined Surgery for the Resectable Huge HCC

Who this might be right for
Hepatocellular CarcinomaHepatic ChemotherapyLiver Cancer+1 more
Sun Yat-sen University 326
Not applicableUnknownNCT03326375
What this trial is testing

Comparison of SBRTand Repeat TACE for HCC

Who this might be right for
HepatoCellular Carcinoma
Gangneung Asan Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01352728
What this trial is testing

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Who this might be right for
Hepatocellular Carcinoma
Chinese University of Hong Kong 50
Testing effectiveness (Phase 2)Ended earlyNCT00667628
What this trial is testing

Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Taiho Oncology, Inc. 54
Not applicableStudy completedNCT00820157
What this trial is testing

Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 120
Not applicableUnknownNCT04967495
What this trial is testing

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 171
Not applicableStudy completedNCT04823715
What this trial is testing

Transarterial Chemoembolization Plus Hypofractionnated Radiotherapy vs. Surgery in Locally Advanced Hepatocellular Carcinoma: an IPTW Comparison

Who this might be right for
Non-metastatic Hepatocellular Carcinoma
Hospices Civils de Lyon 163
Early research (Phase 1)Study completedNCT00478374
What this trial is testing

Sorafenib With TACE to Treat Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Bern 21
Large-scale testing (Phase 3)UnknownNCT05654896
What this trial is testing

Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma

Who this might be right for
Antibiotic Prophylaxis
Nadeem Iqbal 158
Testing effectiveness (Phase 2)Looking for participantsNCT06911255
What this trial is testing

Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)Unresectable Hepatocellular Carcinoma
Yoon Jun Kim 24
Large-scale testing (Phase 3)Looking for participantsNCT05608213
What this trial is testing

Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 187
Not applicableStudy completedNCT07449065
What this trial is testing

CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)Transarterial ChemoembolizationMicrovascular Invasion (MVI)+1 more
First Affiliated Hospital, Sun Yat-Sen University 324
Not applicableLooking for participantsNCT06593964
What this trial is testing

TACE With Thermosensitive Nanogel Versus Embosphere for HCC

Who this might be right for
Unresectable Hepatocellular Carcinoma
Zhongda Hospital 188
Not applicableStudy completedNCT02728219
What this trial is testing

Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion

Who this might be right for
Recurrent Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 150
Large-scale testing (Phase 3)Looking for participantsNCT06555003
What this trial is testing

DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases

Who this might be right for
Liver NeoplasmColorectal Cancer Metastatic
Tehran University of Medical Sciences 116
Post-approval studies (Phase 4)UnknownNCT03518502
What this trial is testing

Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis

Who this might be right for
Hepatocellular CarcinomaMetastasis
Korea University 130
Early research (Phase 1)Study completedNCT04200417
What this trial is testing

Chemoembolization for Lung Tumors

Who this might be right for
Lung MetastasesEndobronchial MetastasesPleural Metastases+1 more
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Study completedNCT03045497
What this trial is testing

Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads

Who this might be right for
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 15
Next Page